Approved comparison material connected to this topic.
17 total recordsSource comparisons are presented without a generated winner.
CJC-1295 with DAC has a plasma half-life of 6–8 days, meaning a single injection sustains elevated GH levels throughout the week. This is mechanistically different from unmodified GHRH analogues like Sermoreli…
Before finalising your protocol, understand how CJC-1295 no DAC compares to other peptides and compounds used for GH elevation. The table below outlines the key differences in mechanism, half-life, dosing freq…
Standard 3x Daily 100mcg 3x per day (morning, post-workout, pre-sleep) Aligns with waking, exercise-induced, and nocturnal pulses 8–12 weeks Muscle hypertrophy, IGF-1 elevation, recovery optimization Gold stan…
CJC-1295's extended half-life distinguishes it from other GHRH analogues and growth hormone secretagogues. The table below compares CJC-1295 with DAC to structurally similar peptides and alternative GH-boostin…
Sleep-Aligned Recovery 100–200mcg 30 min before bed 200–300% increase in nocturnal GH peak General tissue repair, collagen synthesis, sleep quality improvement Most consistent results for overall recovery. Ali…
2× weekly 150–200mcg 300–400mcg 30–60 min before sleep Standard muscle growth protocol. Aligns with extended half-life, minimises injection frequency Optimal for most research applications. Balances convenienc…
Two forms of CJC-1295 exist. DAC (Drug Affinity Complex) and non-DAC (also called Mod GRF 1-29). The names sound like minor variants, but the pharmacokinetics are completely different, and using the wrong form…
| Peptide | Mechanism | Half-Life | Typical Dosing Frequency | IGF-1 Elevation vs Baseline | Receptor Selectivity | Professional Assessment ||—|—|—|—|—|—|| CJC-1295 (with DAC) | GHRH analog with extended half-…
Before finalizing your research protocol, understanding how CJC-1295 no DAC compares to alternative GH-modulating compounds clarifies why pulse protocols require this specific peptide structure. CJC-1295 no DA…
CJC-1295 exists in two primary forms: CJC-1295 with DAC (Drug Affinity Complex) and modified CJC-1295 without DAC, sometimes labelled as 'MOD GRF 1-29'. The DAC modification extends the peptide's half-life fro…
| Protocol Type | Dose (mcg) | Frequency | Timing | Expected Onset | Sleep Architecture Effect | Professional Assessment ||—|—|—|—|—|—|| Conservative Research Protocol | 100–150 mcg | 1x per week | 30–60 min b…
Single Nocturnal Pulse Amplification 100–200mcg Once daily 30 minutes pre-sleep None (monotherapy) Simplest protocol for amplifying natural nocturnal GH pulse; lowest risk of desensitisation Dual-Pulse Protoco…
CJC-1295 with DAC Once weekly 30–60 mcg/kg (2–5mg total for 82kg individual) 6–8 days Sustained GH elevation across entire week. Simplest protocol with fewest injections Slower fat loss onset. Takes 4–6 weeks …
| Protocol Type | CJC-1295 Dose | Ipamorelin Dose | Injection Frequency | Primary Application | Expected Outcome | Professional Assessment ||—|—|—|—|—|—|| Acute Recovery (Post-Competition) | 200mcg | 300mcg | …
GH Pulse Frequency 1 amplified pulse per 24hr 2 amplified pulses per 24hr Sustained elevation (non-pulsatile) Natural pulsatility preserved Twice-daily pulsed mimics natural secretion; continuous blunts recept…
Standard 1:1 Ratio 100mcg 45 min pre-bed Nightly (5–7 days/week) Increased slow-wave sleep duration, improved next-day recovery markers Most reliable starting point. Balanced GHRH and ghrelin pathway activatio…
Standard Synergy 150mcg 250mcg 3×/week (M/W/F) General GH pulse optimisation without daily commitment Ideal starting point. Preserves receptor sensitivity while delivering measurable synergy. Best for research…